Stage 4S neuroblastoma
Information
- Disease name
- Stage 4S neuroblastoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03057626 | Active, not recruiting | Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma | June 5, 2017 | September 30, 2024 | |
| NCT01175356 | Active, not recruiting | Phase 1 | Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin | October 4, 2010 | September 28, 2024 |
| NCT01798004 | Active, not recruiting | Phase 1 | Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | April 8, 2013 | |
| NCT00026312 | Active, not recruiting | Phase 3 | Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma | October 18, 2001 | March 7, 2025 |
| NCT00898391 | Completed | Study of DNA in Blood Samples From Patients With Neuroblastoma | June 2007 | May 2016 | |
| NCT00958659 | Completed | Study of Specimens From Young Patients With Neuroblastoma | December 2008 | May 2016 | |
| NCT01418495 | Completed | Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma | May 26, 2011 | ||
| NCT01208454 | Completed | Phase 1 | Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma | December 2010 | |
| NCT01358617 | Completed | Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma | May 2011 | August 2011 | |
| NCT00033293 | Completed | Phase 3 | Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma | March 15, 2004 | December 31, 2022 |
| NCT00567567 | Completed | Phase 3 | Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | November 5, 2007 | March 31, 2022 |
| NCT00904241 | Recruiting | Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma | November 6, 2000 |